Granules India’s arm gets USFDA nod for Amphetamine Sulfate tablets
The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by company’s subsidiary, Granules Pharmaceuticals Inc, for Amphetamine Sulfate tablets USP 5 mg and 10 mg, Granules India said in a filing to BSE.